Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study

none12noColistin is a last-resort agent for the treatment of infections due to Gram-negative bacteria with difficult-to-treat resistance. The primary objective of this post hoc analysis of a cross-sectional study conducted in 22 Italian hospitals was to assess factors associated with inadequate intravenous colistin dosage. Overall, 187 patients receiving intravenous colistin were included in the analyses. Inadequate colistin dosages were administered in 27% of cases (50/187). In multivariable analysis, AKI (dummy variable with KDIGO stage 0 as a reference, odds ratio (OR) 3.98 with 95% confidence interval (CI) 1.48–10.74 for stage 1, OR 4.44 with 95% CI 1.17–16.93 for stage 2, OR 9.41 with 95% CI 1.59–55.70 for stage 3; overall p = 0.001) retained an independent association with inadequate colistin dosage, whereas the presence of a central venous catheter was associated with adequate colistin dosage (OR: 0.34 for inadequate dosage, 95% CI: 0.16–0.72, p = 0.004). These results were confirmed in an additional multivariable model with the center as a random effect. The association between AKI and inadequate dosage may reflect the perception of an increased risk of nephrotoxicity in patients with impaired renal function, which nonetheless should not be accompanied by dosage reductions beyond those recommended and could represent the target of dedicated antimicrobial stewardship efforts.openGiacobbe D.R.; Mirabella M.; Rinaldi M.; Losito A.R.; Raffaelli F.; Del Puente F.; Saffioti C.; Mikulska M.; Giannella M.; Viale P.; Tumbarello M.; Bassetti M.Giacobbe D.R.; Mirabella M.; Rinaldi M.; Losito A.R.; Raffaelli F.; Del Puente F.; Saffioti C.; Mikulska M.; Giannella M.; Viale P.; Tumbarello M.; Bassetti M